Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cogent Biosciences (COGT) Operating Expenses: 2017-2020

Historic Operating Expenses for Cogent Biosciences (COGT) over the last 4 years, with Dec 2020 value amounting to $90.1 million.

  • Cogent Biosciences' Operating Expenses fell 12.20% to $11.5 million in Q4 2020 from the same period last year, while for Dec 2020 it was $90.1 million, marking a year-over-year increase of 64.73%. This contributed to the annual value of $90.1 million for FY2020, which is 64.73% up from last year.
  • As of FY2020, Cogent Biosciences' Operating Expenses stood at $90.1 million, which was up 64.73% from $54.7 million recorded in FY2019.
  • In the past 5 years, Cogent Biosciences' Operating Expenses registered a high of $90.1 million during FY2020, and its lowest value of $34.5 million during FY2017.
  • Over the past 3 years, Cogent Biosciences' median Operating Expenses value was $54.7 million (recorded in 2019), while the average stood at $63.5 million.
  • Data for Cogent Biosciences' Operating Expenses shows a peak YoY surged of 64.73% (in 2020) over the last 5 years.
  • Over the past 4 years, Cogent Biosciences' Operating Expenses (Yearly) stood at $34.5 million in 2017, then soared by 32.53% to $45.7 million in 2018, then climbed by 19.54% to $54.7 million in 2019, then surged by 64.73% to $90.1 million in 2020.